Pyruvate kinase deficiency is associated with a nonimmune, nonspherocytic hemolytic anemia that may be severe enough to require regular blood transfusions. Grace et al identified factors that can help to identify a patient who is less likely to show a reduction in blood transfusion after the procedure. The authors are from multiple institutions in North America and Europe.